Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7026666 | 0.77 | POLB (0.40) | — | |
| SCHEMBL6734186 | 0.62 | GABRA1 (0.46) | GABRA1GABRB2 | |
| SCHEMBL7031788 | 0.62 | COMT (0.34) | — | |
| SCHEMBL28118419 | 0.62 | — | — | |
| SCHEMBL7026714 | 0.61 | MAPT (0.39) | — | |
| SCHEMBL21737591 | 0.61 | — | — | |
| SCHEMBL7463317 | 0.59 | GLA (0.31) | — | |
| SCHEMBL5414986 | 0.59 | MAPT (0.35) | — | |
| SCHEMBL14404559 | 0.57 | CTRC (0.30) | — | |
| SCHEMBL6432730 | 0.57 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6686478-B2 | NOVEL INTERMEDIATES FOR THEIR PREPARATION; HERBICIDES | BAYER AKTIENGESELLSCHAFT (DE) | 2004-02-03 | — | — | US | disclosed |
| US-20030171595-A1 | Thienylsulphonylamino(thio)carbonyl compounds | MULLER KLAUS-HELMUT (DE) | 2003-09-11 | — | — | US | disclosed |
| US-6566536-B2 | Herbicides | BAYER AKTIENGESELLSCHAFT (DE) | 2003-05-20 | — | — | US | disclosed |
| US-20030004354-A1 | Thienylsulphonylamino(thio)carbonyl compounds | MULLER KLAUS-HELMUT (DE) | 2003-01-02 | — | — | US | disclosed |
| US-6383988-B1 | HERBICIDES | BAYER AKTIENGESELLSCHAFT (DE) | 2002-05-07 | — | — | US | disclosed |
| EP-0942908-B1 | THIENYLSULFONYLAMINO(THIO)CARBONYL COMPOUNDS | BAYER AG (DE) | 2002-02-13 | — | — | EP | disclosed |
| EP-0942908-A1 | THIENYLSULFONYLAMINO(THIO)CARBONYL COMPOUNDS | BAYER AG (DE) | 1999-09-22 | — | — | EP | disclosed |
| WO-1998024787-A1 | THIENYLSULFONYLAMINO(THIO)CARBONYL COMPOUNDS | BAYER AKTIENGESELLSCHAFT (DE) | 1998-06-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030171595-A1 | Thienylsulphonylamino(thio)carbonyl compounds | CBR3, CBR1, QSOX1 | GABRA1 3483/4885GABRB2 3756/4885 |
| US-20030004354-A1 | Thienylsulphonylamino(thio)carbonyl compounds | CBR3, CBR1, QSOX1 | GABRA1 3483/4885GABRB2 3756/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.